Louis Kayitalire - Oct 4, 2021 Form 4 Insider Report for F-star Therapeutics, Inc. (FSTX)

Role
Chief Medical Officer
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Stock symbol
FSTX
Transactions as of
Oct 4, 2021
Transactions value $
-$462
Form type
4
Date filed
10/6/2021, 04:38 PM
Previous filing
Jul 7, 2021
Next filing
Nov 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FSTX Common Stock Sale -$462 -64 -0.12% $7.23 54.3K Oct 4, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
F2 Includes 47,175 restricted stock units.